Pharma Focus America

LATEST NEWSRead more...

23

Jul 2024

Avenacy Introduces Palonosetron Hydrochloride Injection, USP to the U.S. Market

Avenacy a specialty pharmaceutical company dedicated to critical injectable medications has introduced Palonosetron Hydrochloride Injection USP in the US This new product serves as a generic version of Aloxi and has received approval from the US Food and Drug Administration

22

Jul 2024

Immutep Receives FDA Endorsement for Phase III Clinical Trial Strategy in Non-Small Cell Lung Cancer

Immutep Limited a biotechnology firm specializing in LAG immunotherapies for cancer and autoimmune diseases has announced that it has received favorable feedback from the US Food and Drug Administration

20

Jul 2024

Antheia Receives New Funding to Expand Domestic Manufacturing of Essential Pharmaceutical Ingredients

Antheia a company focused on revolutionizing essential medicine supply chains has announced the acquisition of million in new funding This includes a million nondilutive grant from the Biopharmaceutical

19

Jul 2024

ACROBiosystems Introduces New GMP Brand, Resilient Supply, at ISSCR to Enhance Cell and Gene Therapy Development

At the recent International Society for Stem Cell Research Annual Meeting in Hamburg ACROBiosystems introduced its new GMPcentered brand Resilient Supply aimed at accelerating the advancement of cell

19

Jul 2024

Parker Institute Invests Additional $125 Million in Ambitious Cancer Cure Initiative

The Parker Institute for Cancer Immunotherapy has secured a groundbreaking million investment the largest since its inception in This substantial funding boost is set to expand PICIs research

18

Jul 2024

SOTIO and Biocytogen Announce Collaboration to Expand ADC Development with Multi-Target Antibody Agreement

SOTIO Biotech a clinicalstage biopharmaceutical company under PPF Group and Biocytogen a global biotechnology firm listed on the Hong Kong Stock Exchange have entered into a research collaboration

press releasesRead more...

Emergent BioSolutions Announces Shelf-Life Extension for NARCAN® Nasal Spray in Canada

Today Emergent BioSolutions announced the shelflife extension for NARCAN Nasal Spray from three years to four years to all newly manufactured product The update makes NARCAN Nasal Spray the only mg intranasal naloxone spray in Canada

Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement

Hepion Pharmaceuticals Inc a clinical stage biopharmaceutical company that has been developing a treatment for nonalcoholic steatohepatitis hepatocellular

Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.

Aligos Therapeutics Inc a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases today announced that it has entered into a clinical trial collaboration

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate

Zymeworks Inc a clinicalstage biotechnology company developing a diverse pipeline of novel multifunctional biotherapeutics to improve the standard of care for difficulttotreat diseases today announced that the United States

29 - 31

Jul 2024

29 - 31

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

15 - 16

Aug 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

21 - 22

Aug 2024
Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific - mRNA Services
Future Labs Live USA 2024
World Vaccine Congress Europe 2024
World Orphan Drug Congress 2024
Advanced Therapies USA 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    The Role of mRNA Technology Beyond COVID-19 Vaccines: A New Era in Medicine

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 2

    Data Analytics and Forecasting in Pharmaceutical Distribution

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    Addressing the Opioid Crisis: The Role of Pharmaceutical Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    The Future of Pharma: Integrating Imaging Informatics for Better Outcomes

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 5

    Innovative Technologies Driving Vaccine Research and Production: A Revolution in Healthcare

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues